1st Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$121,862
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

National Health Service Corp; Community Health Centers; Health Resource & Services Administration

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); SENATE; White House Office; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA)

Insurance INS

Professional Liability Insurance; Health Insurance

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); White House Office; Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Centers For Disease Control & Prevention (CDC)

Taxation/Internal Revenue Code TAX

Health Savings Accounts; Primary Care Enhancement Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); SENATE; Health Resources & Services Administration (HRSA); White House Office

Health Issues HCR

Medicare Physician Payment Reform; Physician Workforce

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); White House Office; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); SENATE; Government Accountability Office (GAO); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Education EDU

Teaching Health Center Graduate Medical Education; National Health Service Corps; Foreign Medical School Accountability Fairness Act; Single Accreditation

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. VP Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); White House Office; Government Accountability Office (GAO); SENATE; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Executive Office of the President (EOP); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Agency for Healthcare Research & Quality (AHRQ)

Medical/Disease Research/Clinical Labs MED

NIH, FDA

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); Executive Office of the President (EOP); White House Office; Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO); Food & Drug Administration (FDA); Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Office of Management & Budget (OMB); SENATE

Torts TOR

Protecting Access to Care Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Sr. Director of Congressional Affairs

Contacted: Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Agency for Healthcare Research & Quality (AHRQ); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; White House Office; Executive Office of the President (EOP); SENATE; Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Graduate Medical Education; Resident Physician Shortage Act

LobbyistCovered position, as disclosed
MARK LUKASZEWSKI Associate Director, Congressional Affairs
DAVID PUGACH Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Office of Management & Budget (OMB); SENATE; Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); White House Office; Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.